Position Paper: Enhancing Patients’ Access to Advanced Diagnostics
A Proposal for Reform of the French Healthcare System to Allow Broader Adoption of Genomic Testing
Advanced diagnostics have the potential to revolutionize medical care not only in Europe, but around the world. France, for example, is a pioneering country in genomic innovation. However, despite being at the forefront, there are systemic barriers in place that limit access to these cutting-edge diagnostic technologies.
As a result, patients are missing out on high-quality care with suboptimal outcomes, and overall, health systems are overlooking potential cost savings due to inefficient care provision across the entire patient pathway. By overcoming these systemic barriers, the French advanced diagnostic ecosystem can be fundamentally reformed, creating a best practice model for the world, which would improve health outcomes and lower total system costs.
To make this shift happen, Alira Health and EUCOPE have teamed up to create a position paper outlining three key recommendations to enhance the advanced diagnostics ecosystem in France.
Fill in the form below to download Alira Health and EUCOPE’s position paper “Enhancing Patients’ Access to Advanced Diagnostics: A Proposal for Reform of the French Healthcare System to Allow Broader Adoption of Genomic Testing” position paper (available in French). Have questions? Reach out to us at [email protected]
MGFA National Patient Conference 2023
Diversity in Clinical Trials: A Blog Series
How Can Clinical Trials be More Inclusive?
WIRED Health 2023
Challenges to Creating Diversity in Clinical Trials
The Impact of Underrepresentation of Diverse Groups in Clinical Trials
How to Integrate the Patient Voice in Rare Disease Clinical Trials
Subscribe to our newsletter for the latest news, events, and thought leadership